Calvin Goforth, PhD

Calvin Goforth, PhD
Calvin Goforth, PhD, VIC Founder and Chief Executive Officer, has extensive experience in start-up company development in founder, investor, board member, and executive roles. His experience encompasses intellectual property assessment, building strong development teams, raising private investment and government funding, and bringing products to market. He received a BS in Aerospace Engineering with Highest Honors from the University of Texas at Austin.
Find me on:

Recent Posts

VIC 2020 Mid-Year Update

So far, in 2020, VIC’s portfolio of companies reached numerous milestones and potential business partners are increasingly finding ways to re-engage in spite of the ongoing pandemic. The VIC Foundry has expanded...

Why VIC Sometimes Steps Outside Its Life Science Focus

VIC Technology Venture Development primarily is focused on building companies around high-impact life science technologies, including medical devices, therapeutics, diagnostics, and advanced instrumentation. More than...

VIC 2019 Annual Report

In the past year, VIC’s portfolio of companies reached numerous milestones, the VIC Investor Network (VIN) experienced its first exit, and we added important new elements to the VIC ecosystem. While progress in 2019 was...

A Letter from our CEO 2020

Welcome to the 20s! To my ears, 2020 sounds very futuristic – but we are living it. The pace of technological change continues to accelerate and have profound impact on all of us. VIC’s motto is Technology Solutions for...

White Paper: Avoiding Herd Mentality - Sourcing Quality Innovation Beyond The VC Hot Zones

Updated October 2022 Twenty years ago, a two-bedroom apartment in the heart of Silicon Valley would cost an entrepreneur about $1,600 a month. Today, the same apartment would go for $4,000 per month or more. The cost of...

Expanded VIC Investor Network (VIN)

VIC Investor Network Impact healthcare investing for accredited individuals What is the VIC Investor Network? The VIC Investor Network (“VIN”) makes investments into companies that are based on technologies that can...

FEATURED RESOURCES

Updates
VIC Tech Announces New Class of Fellows
Insight
Our Life Science and Healthcare Future
White Paper
Portfolio Diversification in Times of Market Volatility
Interview
Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager
Insight
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
White Paper
Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity
News
Solenic Medical, Inc. Announces $5.1M Series A Funding Round Led by Johnson & Johnson Innovation – JJDC, Inc.
Interview
VIC Fellows Spotlight: Matthew Leming, PhD
From The Corner Office
From the Corner Office: Michael Artinger, PhD – CEO of Solaris Vaccines, Inc.